Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95501665 | 9550166 | 5 | F | 2010 | 20160816 | 20130924 | 20160823 | EXP | PHHY2013BR106188 | NOVARTIS | 0.00 | F | Y | 60.00000 | KG | 20160823 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95501665 | 9550166 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | 21817 | SOLUTION FOR INJECTION | |||||||||
| 95501665 | 9550166 | 2 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | 21817 | SOLUTION FOR INJECTION | |||||||||
| 95501665 | 9550166 | 3 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | 21817 | SOLUTION FOR INJECTION | |||||||||
| 95501665 | 9550166 | 4 | C | METICORTEN | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 95501665 | 9550166 | 5 | C | REUQUINOL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 95501665 | 9550166 | 6 | C | HIPERTIL | 2 | Unknown | UNK | 0 | |||||||||||
| 95501665 | 9550166 | 7 | C | PRESSAT | AMLODIPINE BESYLATE | 1 | Unknown | 0 | |||||||||||
| 95501665 | 9550166 | 8 | C | SOMALGIN | ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95501665 | 9550166 | 1 | Osteoporosis |
| 95501665 | 9550166 | 4 | Product used for unknown indication |
| 95501665 | 9550166 | 5 | Product used for unknown indication |
| 95501665 | 9550166 | 6 | Product used for unknown indication |
| 95501665 | 9550166 | 7 | Product used for unknown indication |
| 95501665 | 9550166 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 95501665 | 9550166 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95501665 | 9550166 | Fall | |
| 95501665 | 9550166 | Foot fracture | |
| 95501665 | 9550166 | Hand fracture | |
| 95501665 | 9550166 | Multiple fractures | |
| 95501665 | 9550166 | Musculoskeletal pain | |
| 95501665 | 9550166 | Upper limb fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 95501665 | 9550166 | 1 | 2008 | 2008 | 0 | |
| 95501665 | 9550166 | 2 | 201306 | 0 | ||
| 95501665 | 9550166 | 3 | 20150921 | 0 | ||
| 95501665 | 9550166 | 4 | 1983 | 0 | ||
| 95501665 | 9550166 | 5 | 1983 | 0 | ||
| 95501665 | 9550166 | 6 | 2012 | 0 |